We have previously reported that CTS treatment or the cholinesterase inhibitor tacrine improves spatial and non-spatial cognitive deficits caused by chronic cerebral hypoperfusion in mice [2,31], indicating a therapeutic potential of CTS for cerebrovascular dementia. Here, BCHE is linked to Cognitive impairment.